has been paid by Ipsen to conduct this study, Ediz Calay: Nothing to Disclose, Allison Smither: nference: Employee, Ipsen: Independent Contractor, Ipsen: Perform research paid for by Ipsen, Ipsen: nference inc is being paid by Ipsen to conduct this study, Tyler Wagner: Anumana, Inc.: Stock privately held company, Dimitar Tonev: Nothing to Disclose, Vitalii Doban: Ipsen Bioscience: Employee, Brian Juran: Nothing to Disclose, Konstantinos Lazaridis: Nothing to Disclose 2364 LIVER STIFFNESS MEASUREMENT BY TRANSIENT ELASTOGRAPHY AS A DYNAMIC PROGNOSTIC INDICATOR FOR DECOMPENSATION, TRANSPLANT, OR DEATH IN PRIMARY SCLEROSING CHOLANGITIS Kristel Leung 1 Bettina Hansen 2 Marwa Ismail 1 Aisha Alawi 1 Aliya Gulamhusein 1 Gideon Hirschfield 1 , 1 Toronto Centre for Liver Disease, University Health Network, University of Toronto, Toronto, Canada, 2 Erasmus Medical Centre, Rotterdam, Netherlands Background: Liver stiffness measurement (LSM) by transient elastography (TE) has been found to be strongly associated with fibrosis stages in primary sclerosing cholangitis (PSC), with cutoffs of 14.4 kPa corresponding to F1/F2, F3, and F4 respectively
[DOI] [PMC free article] [PubMed] [Google Scholar] 35.Rasmussen, S
Cornell, R
However, the peptide also affects subcutaneous fat, particularly in areas with adequate beta-3 receptor expression
